Lutetium Lu 177 Dotatate Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 7.4 GBq/ vial
Reference Brands: Lutathera (USA, EU)
Category:
Oncology Cancer Care
Lutathera is a radiolabeled peptide receptor radionuclide therapy (PRRT) used to treat gastroenteropancreatic neuroendocrine tumors (GEP-NETs) that express somatostatin receptors. It works by delivering targeted radiation directly to tumor cells, minimizing damage to surrounding healthy tissue. The therapy is administered via intravenous infusion under specialized medical supervision, usually in cycles of four doses spaced eight weeks apart.
Lutetium Lu 177 dotatate is available in Injection
and strengths such as 7.4 GBq/ vial.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Lutetium Lu 177 dotatate is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Lutetium Lu 177 dotatate can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing